# K023799: Frios Algipore

- Pathway: 510(k) (Traditional)
- Applicant: Friadent GmbH
- Decided: Feb 5, 2003 after 83 days
- Product code: LYC (Bone Grafting Material, Synthetic)
- Device class: 2
- Regulation: 21 CFR 872.3930
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K950165 (1995). 2 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K950165: Interpore IP 200 Granular Coralline Hydroxyapatite Bone Void Fillers, 425 to 1000 Microns and 425 to 600 Microns, Interpore Intl. (1995) Summary page 1.
- K981214: Osteograf/N-700, Ceramed Dental, LLC (1998) Summary page 1.

## Most influential descendants
- K033110: C-Graft (2003), 0 descendants of its own

## Indications for use
FRIOSB ALGPOWB is indicated for: Treatment of intrabony defects Augmentation of bony defects of alveolar ridge Filling of extraction sites Sinus elevation grafting

Source page: https://510kreport.com/device/K023799
Methodology: https://510kreport.com/methodology
